Mildly oxidized LDL induces expression of group IIa secretory phospholipase A2 in human monocyte-derived macrophages

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 5, 2000, Pages 1276-1282

  Anthonsen, Marit W ^a   Stengel, Dominique ^b   Hourton, Delphine ^b   Ninio, Ewa ^b   Johansen, Berit ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Atherosclerosis; Immunohistochemistry; LDL; Macrophages; Phospholipase A2

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; MEMBRANE PHOSPHOLIPID; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPASE A2;

ARTERY INTIMA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPID PEROXIDATION; MACROPHAGE ACTIVATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034020587     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.5.1276     Document Type: Article

References (46)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. 2 superfamily of signal transduction enzymes. Trends Biochem Sci. 1997;22:1-2.
3. 2). J Biol Chem. 1997;272:15745-15752.
4. 2 is a 100-kDa protein in human monoblast U937 cells. J Biol Chem. 1991;266:5268-5272.
5. 2 from the human monocytic cell line U937. Proc Natl Acad Sci U S A. 1990;87:7708-7712.
6. 2+)-dependent translocation domain with homology to PKC and GAP. Cell. 1991;65:1043-1051.
7. 2. J Biol Chem. 1997;272:16709-16712.
8. 2. J Biol Chem. 1989;264:5768-5775.
9. 2S containing 16 cysteines. J Biol Chem. 1994;269:23018-23024.
10. 2). J Lipid Mediat Cell Signal. 1995;12:83-117.
11. 2 in human fibroblasts. J Biol Chem. 1992;267:23451-23454.
12. 2 by rat mesangial cells: its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J Clin Invest. 1993;92:2516-2523.
13. 2 generation by cultured mouse mast cells following FcεRI-and cytokine-dependent activation. Biochem Biophys Res Commun. 1996;229:726-732.
14. 2) enzymes present in p388d(1) macrophages. J Biol Chem. 1996;271:6758-6765.
15. 2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell. 1995;80:919-927.
16. 2 expression and inflammation: the relationship with associated disease states. J Lipid Mediat. 1993;8:1-30.
17. 2 in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1996;13:70-76.
18. 2 in psoriatic tissue. Inflammation. 1994;18:1-12.
19. 2 in human atherosclerotic plaques. Atherosclerosis. 1995;118:173-181.
20. 2 type II to proteoglycans: differential effect of glycosaminoglycans on enzyme activity. J Biol Chem. 1996;271:26307-26314.
21. 2 in normal and atherosclerotic arteries: activity of the isolated enzyme on low density lipoproteins. Arterioscler Thromb Vasc Biol. 1997;17:300-309.
22. 2 isoforms in human normal and atherosclerotic arterial wall. Arterioscler Thromb Vasc Biol. 1997;17: 2257-2263.
23. 2 in atherosclerosis. Atherosclerosis. 1997;132:1-8.
24. 2 alters the expression of selected apoB-100 epitopes and the interaction of LDL with cells. J Lipid Res. 1988;29:729-743.
25. 2-modified LDL is taken up at enhanced rate by macrophages. Biochem Biophys Res Commun. 1992; 185:465-472.
26. Stengel D, Antonucci M, Arborati M, Hourton D, Griglio S, Chapman MJ, Ninio E. Expression of the PAF receptor in human monocyte-derived macrophages is downregulated by oxidized LDL: relevance to the inflammatory phase of atherogenesis. Arterioscler Thromb Vasc Biol. 1997;17:954-962.
27. Chapman MJ, Laplaud PM, Luc G, Forgez P, Bruckert E, Goulinet S, Lagrange D. Further resolution of the low density lipoprotein spectrum in normal human plasma: physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation. J Lipid Res. 1988;29:442-458.
28. Noble RP. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res. 1968;9:693-700.
29. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302-310.
30. Basu SK, Goldstein JL, Anderson GW, Brown MS. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci U S A. 1976;73:3178-3182.
31. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272:20963-20966.
32. 2 in human leukemia cell lines: its implication for intracellular signaling. Proc Natl Acad Sci U S A. 1994;91:6274-6278.
33. 2 by phosphorylation via protein kinase C in macrophages. FEBS Lett. 1992;311:299-301.
34. 2 enzymes. Proc Natl Acad Sci U S A. 1994;91:11060-11064.
35. 2 in rat renal mesangial cells. Biochim Biophys Acta. 1997;1348:257-272.
36. 2 in human neutrophils. J Biol Chem. 1995;270:26543-26549.
37. 2. EMBO J. 1992;11:4917-4922.
38. Han J, Hajjar DP, Febbraio M, Nicholson AC. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem. 1997;272:21654-21659.
39. Biwa T, Hakamata H, Sakai M, Miyazaki A, Suzuki H, Kodama T, Shichiri M, Horiuchi S. Induction of murine macrophage growth by oxidized low density lipoprotein is mediated by granulocyte macrophage colony-stimulating factor. J Biol Chem. 1998;273:28305-28313.
40. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A. 1990;87:5134-5138.
41. Klouche M, Gottschling S, Gerl V, Hell W, Husmann M, Dorweiler B, Messner M, Bhakdi S. Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages. Arterioscler Thromb Vasc Biol. 1998;18:1376-1385.
42. Smalley DM, Lin JH, Curtis ML, Kobari Y, Stemerman MB, Pritchard KA. Native LDL increases endothelial cell adhesiveness by inducing intercellular adhesion molecule-1. Arterioscler Thromb Vasc Biol. 1996; 16:585-590.
43. Lin JH, Zhu Y, Liao HL, Kobari Y, Groszek L, Stemerman MB. Induction of vascular cell adhesion molecule-1 by low-density lipoprotein. Atherosclerosis. 1996;127:185-194.
44. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993;268:11811-11816.
45. Mahley RW, Ji ZS. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res. 1999;40:1-16.
46. 2. Atherosclerosis. 1997;132:165-176.